Tuesday, July 27, 2021

FDA Authorizes Tocilizumab Monoclonal Antibody for Treatment of COVID-19

FDA Authorizes Tocilizumab for Treatment of COVID-19

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment